These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20031800)

  • 1. Prevention of future cardiovascular disease in high-risk pediatric patients: a role for lipid lowering therapy?
    Pasquali SK; Li JS
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):131-3. PubMed ID: 20031800
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity-related cardiovascular risk factors: intervention recommendations to decrease adolescent obesity.
    Calderon KS; Yucha CB; Schaffer SD
    J Pediatr Nurs; 2005 Feb; 20(1):3-14. PubMed ID: 15834354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A
    Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism.
    Hayman LL; Meininger JC; Daniels SR; McCrindle BW; Helden L; Ross J; Dennison BA; Steinberger J; Williams CL; ; ; ;
    Circulation; 2007 Jul; 116(3):344-57. PubMed ID: 17592077
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance exercise training: its role in the prevention of cardiovascular disease.
    Braith RW; Stewart KJ
    Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of adult heart disease beginning in the pediatric age.
    Berenson GS; Srinivasan SR; Nicklas TA; Johnson CC
    Cardiovasc Clin; 1990; 20(3):21-45. PubMed ID: 2186863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The childhood obesity epidemic: impact on endothelial function.
    Gielen S; Hambrecht R
    Circulation; 2004 Apr; 109(16):1911-3. PubMed ID: 15117859
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood obesity and risk of cardiovascular disease: a review of the science.
    Buiten C; Metzger B
    Pediatr Nurs; 2000; 26(1):13-8. PubMed ID: 12026312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
    McCrindle BW
    Adolesc Med; 2001 Feb; 12(1):147-62. PubMed ID: 11224028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children and cholesterol: potential prevention for future good health.
    Snetselaar LG; Lauer RM
    Bol Asoc Med P R; 1991 Nov; 83(11):505-7. PubMed ID: 1811601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community intervention to screen risk of cardiovascular diseases in a rural Texas community.
    Coustasse-Hencke A; Schutkowski D; Cervantes Y; Rene A
    Tex Med; 2000 Jul; 96(7):50-5. PubMed ID: 10905117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach to reducing cardiovascular risk factors.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S25-36. PubMed ID: 17934391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to identify individuals with elevated cardiovascular risk?].
    Klemsdal TO; Tonstad S; Hjermann I
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):799-801. PubMed ID: 15039814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk: prevention and treatment of the metabolic syndrome.
    Tuomilehto J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S28-35. PubMed ID: 15953504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.